0.799
price down icon0.13%   -0.001
after-market アフターアワーズ: .79 -0.009 -1.13%
loading

Biofrontera Inc (BFRI) 最新ニュース

pulisher
Mar 25, 2025

Benchmark maintains Buy rating on Biofrontera stock, target at $7 By Investing.com - Investing.com Australia

Mar 25, 2025
pulisher
Mar 25, 2025

Biofrontera Inc. (NASDAQ:BFRI) Q4 2024 Earnings Call Transcript - MSN

Mar 25, 2025
pulisher
Mar 25, 2025

Biofrontera Inc. Reports Record Sales and Strategic Advances - MSN

Mar 25, 2025
pulisher
Mar 25, 2025

Benchmark maintains Buy rating on Biofrontera stock, target at $7 - Investing.com India

Mar 25, 2025
pulisher
Mar 22, 2025

Biofrontera outlines 2025 growth strategies with new FDA approvals and clinical progress - MSN

Mar 22, 2025
pulisher
Mar 22, 2025

Biofrontera Full Year 2024 Earnings: Misses Expectations - Yahoo Finance

Mar 22, 2025
pulisher
Mar 22, 2025

Biofrontera Inc (BFRI) Q4 2024 Earnings Call Highlights: Record Revenue Growth Amidst Financial ... By GuruFocus - Investing.com Canada

Mar 22, 2025
pulisher
Mar 21, 2025

Biofrontera Inc. Reports Record Revenue Growth in 2024 - TipRanks

Mar 21, 2025
pulisher
Mar 21, 2025

Biofrontera Inc. reports Q4 EPS (19c) vs $1.65 last year - TipRanks

Mar 21, 2025
pulisher
Mar 21, 2025

Earnings call transcript: Biofrontera Q4 2024 sees revenue growth and strategic shifts - Investing.com India

Mar 21, 2025
pulisher
Mar 21, 2025

Biofrontera Inc reports results for the quarter ended December 31Earnings Summary - TradingView

Mar 21, 2025
pulisher
Mar 21, 2025

Biofrontera Inc. Reports Record Fiscal Year 2024 Financial Results and Provides a Business Update - TradingView

Mar 21, 2025
pulisher
Mar 21, 2025

Biofrontera Inc. Reports Record Fiscal Year 2024 Financial Results and Provides a Business Update - GlobeNewswire Inc.

Mar 21, 2025
pulisher
Mar 21, 2025

Earnings Scheduled For March 21, 2025 - Benzinga

Mar 21, 2025
pulisher
Mar 20, 2025

Biofrontera Inc. (BFRI) reports earnings - Quartz

Mar 20, 2025
pulisher
Mar 20, 2025

Biofrontera Inc. SEC 10-K Report - TradingView

Mar 20, 2025
pulisher
Mar 18, 2025

Biofrontera Completes Patient Enrollment for Phase 3 Trial of Ameluz in Actinic Keratoses - Marketscreener.com

Mar 18, 2025
pulisher
Mar 18, 2025

Biofrontera completes patient enrollment in Phase 3 study of Ameluz - TipRanks

Mar 18, 2025
pulisher
Mar 18, 2025

Biofrontera Inc. Announces Completion of Patient Enrollment - GlobeNewswire

Mar 18, 2025
pulisher
Mar 18, 2025

Major Milestone: Biofrontera's Skin Cancer Treatment Targets New Body Areas in Phase 3 Trial - StockTitan

Mar 18, 2025
pulisher
Mar 18, 2025

3 Reasons to Avoid KIND and 1 Stock to Buy Instead - The Globe and Mail

Mar 18, 2025
pulisher
Mar 14, 2025

Biofrontera (BFRI) to Release Earnings on Friday - Defense World

Mar 14, 2025
pulisher
Mar 11, 2025

Biofrontera Inc. to Report Fourth Quarter and Full Year 2024 Financial Results on March 21, 2025 - GlobeNewswire

Mar 11, 2025
pulisher
Mar 11, 2025

BIOFRONTERA Earnings Preview: Recent $BFRI Insider Trading, Hedge Fund Activity, and More - Nasdaq

Mar 11, 2025
pulisher
Mar 11, 2025

Dermatology Leader Biofrontera Sets Q4 Earnings Date: Key Growth Updates Expected - StockTitan

Mar 11, 2025
pulisher
Mar 06, 2025

Biofrontera (BFRI) Projected to Post Earnings on Thursday - Defense World

Mar 06, 2025
pulisher
Mar 03, 2025

Biofrontera Inc. (NASDAQ:BFRI) Short Interest Down 25.0% in February - Defense World

Mar 03, 2025
pulisher
Feb 27, 2025

Investors Aren't Entirely Convinced By Biofrontera Inc.'s (NASDAQ:BFRI) Revenues - Simply Wall St

Feb 27, 2025
pulisher
Feb 22, 2025

When Will Biofrontera Inc. (NASDAQ:BFRI) Turn A Profit? - Yahoo Finance

Feb 22, 2025
pulisher
Feb 22, 2025

Biofrontera (NASDAQ:BFRI) Trading Down 3.5% – What’s Next? - Defense World

Feb 22, 2025
pulisher
Feb 12, 2025

Constellation Brands: A Fallen Star or a Hidden Value Play? - The Globe and Mail

Feb 12, 2025
pulisher
Feb 03, 2025

Head-To-Head Contrast: Indaptus Therapeutics (NASDAQ:INDP) vs. Biofrontera (NASDAQ:BFRI) - Defense World

Feb 03, 2025
pulisher
Feb 02, 2025

Biofrontera (NASDAQ:BFRI) vs. Sage Therapeutics (NASDAQ:SAGE) Critical Contrast - Defense World

Feb 02, 2025
pulisher
Jan 28, 2025

Biofrontera Inc. Appoints Samantha Widdicombe to Support Commercial Relationships with Strategic Customer Accounts - ACCESS Newswire

Jan 28, 2025
pulisher
Jan 27, 2025

Biofrontera Inc. Announces 2024 Annual Meeting of Stockholders and Deadlines for Submission of Stockholder Proposals - ACCESS Newswire

Jan 27, 2025
pulisher
Jan 26, 2025

Biofrontera Inc. to Report Fourth Quarter and Full Year 2023 Financial Results on March 15, 2024 - ACCESS Newswire

Jan 26, 2025
pulisher
Jan 24, 2025

Biofrontera Inc. Announces Preliminary Third Quarter Revenues - ACCESS Newswire

Jan 24, 2025
pulisher
Jan 08, 2025

Biofrontera says last patient completed one-year follow-up in Ameluz-PDT study - TipRanks

Jan 08, 2025
pulisher
Jan 08, 2025

Biofrontera Inc. Announces Achievement of Key Milestone In - GlobeNewswire

Jan 08, 2025
pulisher
Jan 08, 2025

Biofrontera's Ameluz-PDT Skin Cancer Treatment Hits All Phase 3 Endpoints with Strong Results - StockTitan

Jan 08, 2025
pulisher
Jan 06, 2025

Photonics IP Update: December 2024 - Laser Focus World

Jan 06, 2025
pulisher
Dec 23, 2024

Biofrontera Inc. Announces 100 RhodoLED® XL Machines Now Placed in US Market - The Manila Times

Dec 23, 2024
pulisher
Dec 23, 2024

Biofrontera Hits Major Milestone: 100th RhodoLED® XL Lamp Installed as PDT Treatment Demand Surges - StockTitan

Dec 23, 2024
pulisher
Dec 18, 2024

Opendoor Technologies Inc (OPEN-Q) QuotePress Release - The Globe and Mail

Dec 18, 2024
pulisher
Dec 14, 2024

Financial Contrast: Biofrontera (NASDAQ:BFRI) versus Amicus Therapeutics (NASDAQ:FOLD) - Defense World

Dec 14, 2024
pulisher
Dec 11, 2024

Why Stitch Fix Shares Are Trading Higher By Around 21%; Here Are 20 Stocks Moving Premarket - Benzinga

Dec 11, 2024
pulisher
Dec 04, 2024

Biofrontera Inc (BFRI:UR): Stock Price, Quote and News - BNN Bloomberg

Dec 04, 2024
pulisher
Dec 03, 2024

Biofrontera to Present at Benchmark's Discovery Investor Conference in NYC - StockTitan

Dec 03, 2024
pulisher
Dec 03, 2024

Biofrontera Inc. to Present at The Benchmark Company's Upcoming Discovery One-on-One Investor Conference - Yahoo Finance

Dec 03, 2024
pulisher
Nov 28, 2024

Biofrontera Inc. announced that it expects to receive $4.2 million in funding - Marketscreener.com

Nov 28, 2024
pulisher
Nov 22, 2024

Biofrontera Closes a $4.2 Million Senior Secured Convertible Note - citybiz

Nov 22, 2024
pulisher
Nov 22, 2024

Biofrontera Inc. Closes a $4.2 Million Senior Secured Convertible Note - GlobeNewswire

Nov 22, 2024
$32.53
price down icon 1.48%
$97.93
price up icon 0.34%
$8.60
price down icon 1.26%
$107.00
price down icon 3.25%
$306.88
price down icon 0.45%
$131.87
price down icon 0.04%
大文字化:     |  ボリューム (24 時間):